Oncotarget
Oncotarget. Treatment with NSC74859 improved TUNEL-positive cells inside a dose-dependent manner (Supplementary Number S1A). CAL27 cells were also analyzed by circulation cytometry after Annexin V-FITC and PI dual labeling. As…
Oncotarget. Treatment with NSC74859 improved TUNEL-positive cells inside a dose-dependent manner (Supplementary Number S1A). CAL27 cells were also analyzed by circulation cytometry after Annexin V-FITC and PI dual labeling. As…